Clinical Trial Update: Comparison of Voriconazole and Amphotericin B in Treating Patients With Aspergillosis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing voriconazole to amphotericin B in patients with invasive aspergillosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Aspergillosis

Drugs mentioned

• Amphotericin B (Amphotericin B)
• VORICONAZOLE (Voriconazole)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Infection, Pulmonary Complications | Phase 3 | Status: COMPLETED